| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00125-015-3634-4 |
| P698 | PubMed publication ID | 26032022 |
| P50 | author | Catherine Postic | Q42128947 |
| P2093 | author name string | Jean-Pierre Couty | |
| Alison Iroz | |||
| P2860 | cites work | Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance | Q42832316 |
| The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes | Q45834496 | ||
| Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans. | Q51379199 | ||
| Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver. | Q54372891 | ||
| Effects of parabiosis of obese with diabetes and normal mice | Q69634353 | ||
| Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction | Q74191142 | ||
| Fibroblast growth factor 21 analogue LY2405319 lowers blood glucose in streptozotocin-induced insulin-deficient diabetic mice by restoring brown adipose tissue function | Q85893184 | ||
| ANGPTL8/betatrophin does not control pancreatic beta cell expansion | Q24307433 | ||
| RETRACTED: Betatrophin: a hormone that controls pancreatic β cell proliferation | Q24339335 | ||
| Inventing new medicines: The FGF21 story | Q26823319 | ||
| Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes | Q28571616 | ||
| Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states | Q29615208 | ||
| A link between hepatic glucose production and peripheral energy metabolism via hepatokines | Q33906438 | ||
| Fructose ingestion acutely stimulates circulating FGF21 levels in humans | Q35040490 | ||
| Direct inhibitory effects of pioglitazone on hepatic fetuin-A expression | Q35097489 | ||
| Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice | Q35698850 | ||
| Liver-derived systemic factors drive β cell hyperplasia in insulin-resistant states. | Q36848210 | ||
| Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease | Q36889026 | ||
| Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes | Q37374259 | ||
| The role of hepatokines in metabolism | Q38075770 | ||
| FGF21-based pharmacotherapy--potential utility for metabolic disorders | Q38202720 | ||
| Angiopoietin-like protein 8 (ANGPTL8)/betatrophin overexpression does not increase beta cell proliferation in mice | Q41862381 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1699-1703 | |
| P577 | publication date | 2015-06-02 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Hepatokines: unlocking the multi-organ network in metabolic diseases | |
| P478 | volume | 58 |
| Q42378996 | A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response |
| Q47195087 | Association Between Urinary Alpha1-Microglobulin Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study |
| Q44390101 | Association between Healthy Eating Index-2010 and Fetuin-A Levels in Patients with Type 2 Diabetes: a Case-Control Study |
| Q36334120 | Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis |
| Q48179147 | Association of serum betatrophin with fibroblast growth factor-21 in women with polycystic ovary syndrome. |
| Q33852008 | Carbohydrates from Sources with a Higher Glycemic Index during Adolescence: Is Evening Rather than Morning Intake Relevant for Risk Markers of Type 2 Diabetes in Young Adulthood? |
| Q48037644 | Diabetologia at 50: celebrating half a century of progress in diabetes research and care |
| Q61445459 | Effects of exercise training on Fetuin-a in obese, type 2 diabetes and cardiovascular disease in adults and elderly: a systematic review and Meta-analysis |
| Q57687713 | European Obesity Summit (EOS) - Joint Congress of EASOand IFSO-EC, Gothenburg, Sweden, June 1 - 4, 2016: Abstracts |
| Q51027541 | Expression of angiopoietin-like protein 8 correlates with VEGF in patients with proliferative diabetic retinopathy. |
| Q47291127 | Fetuin-A, adiposity-linked insulin resistance and responsiveness to an educational-based weight excess reduction program: a population-based survey in prepubertal schoolchildren |
| Q39168770 | Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism |
| Q92219736 | Hepatoprotective Effects of a Ruthenium(II) Schiff Base Complex in Rats with Diet-Induced Prediabetes |
| Q92422669 | Identification of the Secreted Proteins Originated from Primary Human Hepatocytes and HepG2 Cells |
| Q26751147 | Implication of hepatokines in metabolic disorders and cardiovascular diseases |
| Q38728754 | Liver innate immune cells and insulin resistance: the multiple facets of Kupffer cells |
| Q26745839 | Mechanisms of Diabetes-Induced Liver Damage: The role of oxidative stress and inflammation |
| Q104484239 | New Emerging Roles of the Novel Hepatokine SERPINB1 in Type 2 Diabetes Mellitus: Crosstalk with β-Cell Dysfunction and Dyslipidemia |
| Q41663528 | Organ-Organ Crosstalk and Alcoholic Liver Disease |
| Q35928495 | Pathogenesis of nonalcoholic steatohepatitis |
| Q86743265 | Plasma fetuin-A does not correlate with monocyte TLR4 in humans |
| Q39145046 | Postweaning changes in the expression of chemerin and its receptors in calves are associated with the modification of glucose metabolism |
| Q61455151 | Relationship of Circulating Fetuin-A Levels with Body Size and Metabolic Phenotypes |
| Q47365110 | Relationship of Serum Fetuin A with Metabolic and Clinical Parameters in German Children and Adolescents with Type 1 Diabetes |
| Q26753189 | The Impact of Organokines on Insulin Resistance, Inflammation, and Atherosclerosis |
| Q36413070 | The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies |
| Q38845636 | The potential of endurance exercise-derived exosomes to treat metabolic diseases. |
| Q36302698 | Visceral fat area is a strong predictor of leukocyte cell-derived chemotaxin 2, a potential biomarker of dyslipidemia |
Search more.